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Abstract 
Objective People with diabetic neuropathy who have previously ulcerated are at high 
risk of re-ulceration. They should regularly attend podiatry clinics for surveillance and routine 
protective podiatric treatment. It has been suggested that inflammation prior to skin 
breakdown shows up as a hotspot on a thermal image even in the absence of clinical signs. 
The aim of this study is to quantify inter-patient and intra-patient thermal variations presented 
by diabetic feet at high risk of ulceration.  
Approach Whole foot and spot temperatures were recorded for 96 patients who 
attended two successive podiatry appointments without ulceration 28 [28, 31] days apart, 
median [interquartile range]. This was a part of a longer study into whether thermal imaging 
in clinic can reduce the rate of re-ulceration.  
Main results The variation in spot temperature right/left differences for single patients 
between visits was comparable to the variation observed between patients (0.8 [0.3,1.5] °C 
compared with 0.9 [0.4,1.7] °C). Similarly, whole foot temperature variation for a single 
patient between visits was comparable to the variation observed between patients (0.6 
[0.2,1.1] °C compared with 0.8 [0.2,1.3] °C).  
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Significance Thresholds which depend on thermal differences from visit to visit are 
unlikely to have sufficient specificity to effectively target treatment designed to prevent the 
development of foot ulcers.  
Keywords: thermography, diabetic foot, infrared imaging 
 
1. Introduction 
People with diabetes can sometimes develop neuropathy, 
particularly in feet and hands. Neuropathy is damage to the 
somatosensory nervous system which impairs the person’s 
sensation of touch and temperature. This deficit often results 
in greater incidence of injury to the skin. Coupled with an 
impaired healing mechansim due to high levels of blood 
glucose compromising blood supply to wounds, diabetic 
neuropathy greatly incresases the risk of ulcers, particularly 
on the feet. About 10% of people with diabetes will have a 
diabetic foot ulcer at some point in their lives [1] and up to 
85% of these are associated with neuropathy [2]. Patients at 
high risk of ulcers are usually invited to their local podiatry 
clinic regularly and are encouraged to report any warning 
signs between appointments. However, often ulcers will 
develop without any apparent warning. It has been suggested 
that ulcers due to repeated pressure and/or shear forces may 
be preempted by inflammation of the skin [3] and this 
inflammation may be characterised by localised warming of 
the skin. If thermal symmetry in healthy feet is assumed then 
local warming will generate a measureable asymmetry. 
Several studies have been carried out which demonstrated a 
reduction in ulceration rates through regular bilateral spot 
temperature measurements at home and acting on asymmetry 
observed [4,5]. However, the authors are not aware of more 
recent studies which have been able to reproduce these 
results [6]. Spot temperature measurement is time consuming 
for patients and thermal imaging is the logical next step. A 
thermal image of both feet will instantaneously ‘map’ 
temperatures and allow for easy identification of areas of 
increased temperature. The utility of this development has 
been investigated by several researchers [7,8] but none have 
studied a large cohort of patients over significant periods of 
time. 
 
1.1 A national collaboration 
The data reported in this paper are the result of a major 
collaborative project funded by the government’s i4i research 
scheme through the National Institute for Health Research. 
Three clinical centres across England recruited patients to the 
studies arising from the project. Photometrix Imaging, 
Pontypridd, Wales, developed the bespoke cameras used in 
the investigation (known during the project as the Diabetic 
Foot Ulcer Prevention System, or DFUPS) and scientists at 
the National Physical Laboratory, Teddington, London, 
characterised the cameras and contributed administrative and 
specialist scientific support. The patient studies carried out 
were; an intial comparison of thermal imaging with spot 
temperature measurements in people at no clinical risk of 
foot ulceration; and a longer randomised control trial 
involving multiple visits by patients at high risk of foot 
ulceration. In the first trial the imaging technique was easily 
shown to be more convenient and in agreement with spot 
temperature measurements carried out using a hand held 
infrared device [9]. The second trial was designed to 
investigate whether using DFUPS in clinic could reduce the 
reoccurrence of foot ulcer over one year. At time of writing 
the results of this second, longer, study are being prepared 
for publication. In the course of the randomised control trial 
thermal images of both feet at multiple visits were gathered. 
It is data from the first two clinic visits which are being 
presented in this paper. The aim of this study is to quantify  
inter-patient and intra-patient thermal variations presented by 
diabetic feet at high risk of ulceration. 
 
2. Method 
Patients with diabetic neuropathy and a history of at least 
one previous foot ulcer were recruited at podiatry 
departments within Newcastle upon Tyne Hospitals 
Foundation Trust, Pennine Acute Hospitals Trust and King’s 
College Hospital Foundation Trust. These patients fall into 
the highest risk category, 3, for foot ulceration as defined by 
the International Working Group on the Diabetic Foot 
(IWGDF) in their 2015 Guidance on the prevention of foot 
ulcers in at-risk patients with diabetes [10]. The study was 
approved by London-Surrey Borders Research Ethics 
Committee (REC reference 15/LO/1940) and carried out in 
accordance with the Declaration of Helsinki. The study was 
registered on the ClinicalTrials.gov website (identifier 
NCT02579070). The study protocol was explained to 
suitable patients and consent taken. Neuropathy was 
confirmed by a vibration perception threshold (VPT) 
>25volts on at least one foot using a neurothesiometer and 
patients were excluded if they had any history of peripheral 
arterial disease, absence of palpable pulses for both the 
posterior tibial artery and dorsalis pedis artery on either foot, 
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an implantable electronic device, amputation or deformity 
which in the opinion of the study investigator would 
confound the comparison of contralateral foot sites (for 
example overriding toes or unilateral toe amputation), active 
Charcot neuroarthropathy or broken skin. Non-confounding 
foot deformities such as prominent metatarsal heads, rocker 
bottom Charcot foot deformity, medial convexity Charcot 
foot deformity, prominent styloid process of the 5th 
metatarsal base and pes cavus (high arch, clawed toes, 
prominent metatarsal heads) were not excluded. Recruited 
patients were asked to sit for 10 minutes with their feet 
elevated and bare in a temperature-controlled room before 
the DFUPS device was used to image all four aspects of each 
foot; plantar, dorsal, medial and lateral. Another period of 10 
minutes rest followed ending in a second round of images in 
order to rule out any transient asymmetries in skin 
temperature. Patients were randomised into either an 
interventional or control group. All patients were given 
routine podiatry treatment which, in the case of the 
interventional group, was informed by the thermal images. 
Hotspots, that is contralateral areas of asymmetry measuring 
a difference of 2.2 °C or more, were given special attention 
and patients invited back sooner for their next podiatry 
appointment. If a hotspot was noted on the first set images 
(captured after 10 minutes rest) then the same spot on the 
second set of images (captured after a further 10 minutes of 
rest) was analysed to confirm the presence of a ‘persistent’ 
hotspot rather than a ‘transient’ hotspot [11]. Also, 2.2 °C 
differences which, in the opinion of the podiatrist, were due 
to localised cold areas instead of hot areas were not counted 
as hotspots. Standard reappointment intervals were four 
weeks. This was reduced to 2 weeks or even 1 week if the 
podiatrist had any particular concerns. 
 
2.1 Diabetic Foot Ulcer Prevention System 
   The DFUPS devices encompass a Micro-Epsilon TM 
400 thermal camera which has 382x288 pixels and a stated 
thermal resolution of 0.08 °C. They were characterised by 
NPL to assess the temperature resolution, the spatial 
resolution and performance (repeatability, stability and 
accuracy). All devices were calibrated under laboratory 
conditions in terms of radiance temperature versus the NPL 
blackbody calibration sources [12] over the range of 15 °C to 
45 °C, traceable to the international temperature scale of 
1990 (ITS-90) with uncertainties of ±0.2 °C (k = 2, 95% 
confidence limit) quantified in accordance with the 
internationally agreed Guide to Uncertainty in Measurement 
(http://www.bipm.org/utils/common/documents/jcgm/JCGM
_100_2008_E.pdf ). The device was marked for Clinical 
Investigation and designed specifically for the patient studies 
in clinic. Bespoke software directed the imaging sequence 
and post-imaging analysis.  
 
2.2 Demography 
Patients had their age, sex, height and weight recorded. In 
addition to that VPT, ulceration history, diabetes type and 
duration were recorded.  
 
2.3 Analysis 
Post visit analysis of the images captured after 10 minutes 
rest was performed by a single investigator and involved 
recording the temperatures at thirty three regions of interest 
(ROIs) on both feet. The ROI locations are illustrated in 
figure 1, namely the toe apexes, metatarsal heads, 5th 
metatarsal base and the heel on the plantar surface; the 
interphalangeal joints, metatarsophalangeal joints and 





 metatarsal base and malleolus on the medial surface; 
the 5
th
 metatarsophalangeal joint, the base of the 5
th
 
metatarsal and the malleolus on the lateral surface. The 
temperatures of the 33 ROIs were averaged in order to 
calculate a mean foot temperature (MFT33). The difference 
between feet was compared to a threshold of 1.35 °C which 
was proposed by van Netten et al. in their study of patients 
with diabetes [13]. However, their mean foot temperature 
was derived from outlining the plantar foot rather than using 
multiple smaller ROIs. Temperature difference, dT, between 
contralateral ROIs, i.e. Right—Left (R-L) values at each ROI 
site, was also recorded. When quantifying differences in dT 
between patients signless dT was also used, that is ‘warmest 
spot – coolest spot’. This is because measurements of dT on 
feet where the right foot ROI is warmer will tend to cancel 
out those where the left foot ROI is warmer. When 
quantifying differences in dT and MFT33 between visits 
±sign was taken into account in order to not mask a change 
in hottest foot. This is explained in more detail in the results 
tables legends. 
ROI temperatures from two consecutive podiatry 
appointments were collected and compared for all ROI sites 
and median and interquartile range calculated. Also, intra-
patient variation (from visit to visit for the same person) and 
inter-patient variation (between people at a single visit) were 
quantified. 
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Figure 1: Location of 33 regions of interest analysed on the 
thermographic images (first published in Macdonald et al. Physiol. 
Meas. 38 33–44) 
3. Results 
Table 1 summarises the demographic data for 96 patients 
with diabetic neuropathy (74 male, age 63.1 ± 10.8 years, 
mean ± standard deviation) who were imaged at two visits 28 
[28, 31] days apart (median [IQR]) and did not ulcerate in 
that time. Room temperature was recorded as 23.0 ± 1.0 °C 
at the first visit and 23.4 ± 1.2 °C at the second visit (mean ± 
standard deviation). Table 2 describes the results of the 
temperature analysis. Table 3 details the results by individual 
ROIs. 
The two visits result in almost identical variability data, 
therefore there is no evidence of visit bias. The median 
temperature difference between contralateral sites on the foot 
is almost 1 °C. The temperature difference between 
contralateral ROIs, dT, varies practically as much from visit 
to visit for the same person as it does between people at a 
single visit (0.8 °C compared with 0.9 °C). Also, the 
temperature difference between whole feet, as measured by 
MFT33, varies almost as much from visit to visit for the 
same person as it does between people at a single visit (0.6 
°C compared with 0.75 °C). In other words, for both spot 
differences and MFT33 differences, the intra-patient 
variation is comparable to inter-patient variation (where the 
former is calculated from two visits several weeks apart). For 
the group overall, left whole foot temperatures (L MFT33) 
are comparable to right whole foot temperatures (R MFT33) 
although the average difference between them is 0.75 °C.  
Individual MFT33 varies by a median of 1.2 °C between 
visits but the MFT33 average for the group overall is very 
similar at both visits.  
17% of the dT measurements made at the first visit exceed 
the published threshold, 2.2 °C, proposed in earlier papers as 
significant in the detection of imminent foot ulcers. This 
proportion is 20% for visit 2.  
25% of the MFT33 difference measurements made at the 
first visit exceed a threshold of 1.35 °C. This proportion is 
31% for visit 2. The detailed dT data in table 3 reveal that the 
proportion of patients with asymmetry over 2.2 °C at a 
specific ROI ranges between 7-30% with the malleoli 
demonstrating the least asymmetry and the plantar toes 
demonstrating the greatest asymmetry. The plantar toes also 
exhibit the greatest variability from visit to visit. Overall, at 
the first visit, 64 patients (67%) had at least one ROI with 
asymmetry exceeding 2.2 °C. When transient hotspots and 




One of the limitations of this study and analysis is that 
patients in the interventional group potentially had hotspot-
directed treatment whereas the control group did not. This 
may have changed the presentation of thermal differences for 
the interventional group at their second visit. However, since 
the spread of temperature differences were comparable over 
the two visits and none of the included patients developed an 
ulcer we are confident that targeted treatment did not cause a 
measureable effect. Another limitation was that assessment 
of whether a hotspot was in fact a coldspot was a subjective 
assessment made at the time of the appointment. Finally, the 
recording of thermal images at patients’ routine podiatry 
clinic visits precluded repeating the measurements the 
following day as practiced by investigators in previous 
studies [4,5,6,14]. This additional study of daily variation 
would have added greatly to our understanding. 
However, since thermography is increasingly being 
suggested as a tool in the monitoring of disease, specifically 
inflammation, it is important to know what typical variation 
is amongst patients who do not present the looked-for 
pathology. In this case we were looking for areas at risk of 
skin breakdown. Patients presented with intact feet and, after 
thermal imaging,  were given typical protective prophylactic 
podiatric treatment designed to minimise that risk. Many 
regions of interest demonstrated elevated temperature when 
compared with the contralateral site. The proportion was 
greater than the 5% observed in a study of healthy feet [11] 
and also greater than the 8.5% observed by Wijlens et al. 
[14] in a small cohort of patients who were in lower IWGDF 
ulceration risk categories. Interpretation of these results is 
not straightforward since we have anecdotally noted 
examples of hot areas which correlate with clinically 
significant visual observations (such as callus), hot areas 
which have no obvious visible clinical sign (see figure 2), 
and areas which are visibly red or vulnerable which do not 
show up as hot areas on the thermogram. This has been noted 
before by other researchers [13]. 
This study is not being described as investigating the 
reproducibility of thermal images since the participants had 
ongoing routine podiatric treatment and unknown factors 
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such as wearing different shoes between visits. Indeed, 42% 
of the participants were in the interventional group which 
meant their podiatric treatment and advice were based, in 
part, on the thermographic images taken in clinic. The 
purpose of this analysis, however, is to describe the 
thermographic variability that is commonly observed in this 
high risk cohort during routine management. Routine 
management does not protect against all ulcers and there is 
an urgency to find additional means to help in the battle. In 
this study, the evidence suggests that the use of thermal 
imaging in clinic to highlight areas of impending ulceration 
is confounded by unexplained thermal patterns. 
 
The increased observation of hotspots in this high risk 
group compared with the healthy feet cohort studied earlier 
may have other explanations apart from pressure- or shear-
induced inflammation. It was interesting to note that the 
neuropathic, high-risk cohort hotspots were very much less 
likely to be ruled out as ‘transient’ (based on the second set 
of images taken 10 minutes later). Patients with diabetic 
neuropathy have sensory neuropathy and may also have a 
degree of autonomic neuropathy impairing vasoregulation. It 
is possible that the impairment is not uniform across different 
areas of the foot thereby introducing greater thermal 
assymetry than is found in healthy feet. This possibility does 
not necessarily make thermal imaging redundant. It could be 
expected that asymmetry due to non-uniform neuropathy 
would be fairly consistent, although the variability data for 
ROIs between visits does not support this. There are grounds 
for imaging people much more frequently, perhaps daily, and 
monitoring changes to their typical thermographic 
presentation. However, daily imaging increases the 
challenges to a study involving thermography. If participants 
were to do their own imaging in the home, for example, the 
camera would need to be more affordable and simple to use, 
and a pared down protocol devised which had a reasonable 
chance of adherence to it. This concept is already being 
explored in the form of an infrared camera which can be 
attached to a smartphone [15]. 
 
 
Figure 2: Example thermogram of a patient with diabetic 
neuropathy (colour scale is in °C). The hot area did not correlate 
with any visible clinical signs and did not break down during the 
course of the study. NB this patient was in the control group 
therefore the hot area was not revealed or specifically protected by 
podiatric treatment at the first visit. 
5. Conclusion 
Localised hot areas on the skin have been of interest to 
clinicians seeking to diagnose skin vulnerable to ulceration. 
Our study demonstrated many hotspots on the feet of patients 
at high risk of diabetic foot ulcer, and quantified the variation 
seen from visit to visit. However, understanding of the 
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Age (yrs) 63.1 ± 10.8 yrs 
Sex ( Male : Female )  74 : 22 
Height (m) 1.76 ± 0.10 m 
Weight (kg) 95.6 ± 22.0 kg 
BMI (kgm-2) 30.7 ± 6.6 kgm-2 
VPT (left, right) 40.0 [29.0,49.0] V, 39.0 [27.1,48.5] V 
Number previous ulcers 1.8 ± 1.1 
Diabetes type ( 1 : 2 ) 27 : 69 
Diabetes duration  19 [10,27] yrs 
Table 1: Demographics of 96 patients with diabetic neuropathy (mean ± SD, median [IQR]).  
 
 Visit 1 Visit 2 
 Median [IQR]  (°C) % > threshold* Median [IQR]  (°C) % > threshold* 
dT 0.2    [-0.6, 1.1] 17 0.1    [-0.7, 1.1] 20 
Signless dT 0.9    [0.4, 1.7] 17 0.9    [0.4, 1.8] 20 
R MFT33 30.0  [27.2, 31.8] n/a 29.9  [28.0, 31.8] n/a 
L MFT33 29.4  [27.4, 31.8] n/a 29.7  [27.6, 31.8] n/a 
R-L MFT33 0.1    [-0.5, 0.8] 25 0       [-0.8, 0.7] 31 
Signless diff in 
MFT33 
0.8    [0.2, 1.3] 25 0.7    [0.2, 1.4] 31 
 
 Visit 2 - Visit 1 
Change in dT -0.1   [-0.8, 0.7] n/a 
Signless Change in dT 0.8    [0.3, 1.5] n/a 
Signless Change in R MFT33 1.2    [0.5, 2.2] n/a 
Signless Change in L MFT33 1.3    [0.4, 2.4] n/a 
Signless Change in R-L MFT33 0.6    [0.2, 1.1] n/a 
Table 2: Temperature differences between 33 contralateral regions of interest (ROIs) at each of two visits by 96 patients with diabetic 
neuropathy 28 [28, 31] days apart (median [IQR]). dT (relative difference in temperature at ROIs, R-L); Signless dT (absolute difference in 
temperature at ROIs, i.e. warmest spot – coolest spot); MFT33 (Mean foot temperature derived from all 33 ROIs); Change in dT (change 
observed between visits, calculated for 33 ROIs on every patient); Signless Change in dT (change in temperature asymmetry at ROIs 
observed between visits regardless of whether the asymmetry improved or worsened at visit 2); Signless Change in R MFT33 (change in R 
foot temperature observed between visits regardless of whether the foot became warmer or colder at visit 2); Signless Change in R-L 
MFT33 (change in MFT33 asymmetry observed between visits regardless of whether the feet became more or less symmetrical but not 
disregarding the greater change which would occur if the opposite foot became the warmer one. For example, if the R-L MFT33 
measurement at visit 1 was 0.2 °C and the R-L MFT33 measurement at visit 2 was -0.9 °C the Visit 2 – Visit 1 value is 1.1 °C). *Threshold 
for ROI dT measurements is 2.2°C (1,2), threshold for MFT33 measurements is 1.35°C [13]. n/a = not applicable 
 
 
 Visit 1 Visit 2 Visit 2 – Visit 1 
ROI Median [IQR]  (°C) % ≥ 2.2 °C Median [IQR]  (°C) % ≥ 2.2 °C Median [IQR]  (°C) 
Plantar      
    1st toe apex 1.0 [0.4, 2.1] 23 1.0 [0.4, 2.6] 30 1.2 [0.5, 2.1] 
    2nd toe apex 0.9 [0.4, 2.2] 24 1.0 [0.4, 2.2] 25 0.9 [0.3, 2.2] 
    3rd toe apex 1.0 [0.4, 2.0] 20 1.0 [0.5, 1.9] 23 0.9 [0.4, 1.9] 
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    4th toe apex 1.0 [0.4, 1.8] 21 1.1 [0.5, 2.1] 24 1.0 [0.4, 1.5] 
    5th toe apex 1.0 [0.3, 1.9] 18 0.9 [0.3, 2.1] 22 0.9 [0.4, 2.1] 
    1st metatarsal head 0.9 [0.4, 2.1] 23 0.9 [0.5, 2.0] 23 1.0 [0.4, 1.7] 
    2nd metatarsal head 1.1 [0.4, 1.9] 19 1.0 [0.4, 1.8] 21 1.0 [0.4, 1.8] 
    3rd metatarsal head 0.9 [0.5, 1.8] 20 0.9 [0.5, 2.0] 23 0.8 [0.3, 1.5] 
    4th metatarsal head 1.0 [0.5, 1.6] 13 0.9 [0.3, 2.0] 20 0.7 [0.4, 1.6] 
    5th metatarsal head 1.0 [0.4, 1.7] 15 1.0 [0.5, 1.8] 21 0.9 [0.3, 1.6] 
    5th metatarsal base 0.7 [0.3, 1.4] 11 0.9 [0.3, 1.6] 17 0.8 [0.3, 1.4] 
    Heel 0.8 [0.4, 1.4] 16 0.9 [0.5, 1.7] 16 0.8 [0.4, 1.4] 
Dorsal      
    1st interphalangeal joint 0.9 [0.4, 2.0] 22 1.1 [0.3, 2.5] 29 0.8 [0.4, 2.0] 
    2nd interphalangeal joint 0.9 [0.4, 2.1] 22 0.9 [0.3, 2.4] 28 1.0 [0.4, 1.9] 
    3rd interphalangeal joint 0.9 [0.4, 1.8] 16 0.9 [0.5, 1.9] 24 0.9 [0.4, 1.6] 
    4th interphalangeal joint 0.9 [0.4, 1.9] 19 1.1 [0.4, 2.2] 26 1.0 [0.4, 1.5] 
    5th interphalangeal joint 1.0 [0.4, 1.8] 20 0.9 [0.4, 1.9] 23 0.9 [0.3, 1.8] 
    1st metatarsophalangeal joint 0.8 [0.3, 1.7] 18 0.8 [0.4, 1.9] 20 0.7 [0.3, 1.5] 
    2nd metatarsophalangeal joint 0.8 [0.4, 1.8] 15 0.7 [0.3, 1.8] 21 0.7 [0.3, 1.4] 
    3rd metatarsophalangeal joint 0.9 [0.4, 1.6] 14 0.6 [0.3, 1.7] 21 0.6 [0.3, 1.3] 
    4th metatarsophalangeal joint 0.8 [0.4, 1.5] 16 0.8 [0.3, 1.7] 21 0.8 [0.3, 1.3] 
    5th metatarsophalangeal joint 0.8 [0.4, 1.5] 13 0.9 [0.4, 1.7] 17 0.8 [0.2, 1.4] 
    1st tarsometatarsal joint 0.8 [0.4, 2.0] 20 0.8 [0.3, 1.6] 14 0.6 [0.2, 1.3] 
    2nd tarsometatarsal joint 0.8 [0.4, 1.4] 16 0.9 [0.4, 1.6] 13 0.5 [0.2, 1.2] 
    3rd tarsometatarsal joint 0.7 [0.3, 1.7] 16 0.8 [0.3, 1.7] 17 0.6 [0.3, 1.1] 
    4th tarsometatarsal joint 0.8 [0.3, 1.5] 13 0.8 [0.4, 1.5] 16 0.7 [0.3, 1.1] 
    5th tarsometatarsal joint 0.9 [0.4, 1.6] 14 0.8 [0.3, 1.6] 15 0.8 [0.4, 1.4] 
Medial      
    1st metatarsal head 0.6 [0.3, 2.0] 23 0.8 [0.4, 2.0] 23 1.0 [0.4, 1.9] 
    1st metatarsal base 0.8 [0.3, 1.5] 13 1.0 [0.3, 1.7] 14 0.7 [0.3, 1.4] 
    Malleolus 0.8 [0.4, 1.3] 7 0.8 [0.4, 1.3] 10 0.6 [0.4, 1.1] 
Lateral      
    5th metatarsophalangeal joint 0.9 [0.4, 1.6] 13 1.0 [0.4, 1.8] 18 0.7 [0.3, 1.5] 
    5th metatarsal base 0.7 [0.3, 1.2] 13 0.7 [0.3, 1.4] 18 0.6 [0.3, 1.3] 
    Malleolus 0.6 [0.3, 1.3] 9 0.9 [0.4, 1.3] 11 0.6 [0.3, 1.2] 
Table 3: Temperature differences between contralateral regions of interest (ROIs) at each of two visits by 96 patients with diabetic 
neuropathy 28 [28, 31] days apart (median [IQR]) expressed as Signless dT (absolute difference in temperature at ROIs, i.e. warmest spot – 
coolest spot). Visit 2 – Visit 1 is the change in dT observed between visits regardless of whether the feet became more or less symmetrical 
at the ROI but not disregarding the greater change which has occurred if the contralateral foot ROI became the warmer one (for example, if 
the R-L dT measurement at visit 1 was 0.5 °C and the R-L dT measurement at visit 2 was -1.2 °C the Visit 2 – Visit 1 value is 1.7 °C). 
 
